query
stringlengths
54
767
positive
stringlengths
1.02k
2k
negative
stringlengths
1k
2k
Agilent's test and measurement business targets high-growth wireless and Internet communications markets by providing test solutions ranging from under $1,000 to over $1 million for components, network equipment, and contract manufacturers. The company leverages collaborative relationships with major entities like Noki...
to be developed to enable testing of the new standards in the research and development and later in the manufacturing and deployment phases. We believe that in the last several years, producers of networking communications equipment have increased their use of contract manufacturers. Contract manufacturers require test...
e categorized as Level 3. A non-pricing service source prices certain privately placed corporate bonds using a model with observable inputs including, but not limited to, the credit rating, credit spreads, sector add-ons, and issuer specific add-ons. A non-pricing service source prices our CPI Caps using a model with i...
The semiconductor products business generated $2.2 billion in revenue in fiscal year 2000, up from $1.7 billion in 1999 and $1.6 billion in 1998, employing approximately 10,200 people. The company serves the communications and computing markets, supplying components to major entities including Hewlett-Packard, Alcatel,...
rease. We believe that the principal factors of competition are: - speed, accuracy and cost of test; - breadth of product offerings; - scalability and flexibility of products; - ease of product use; - ability to upgrade product platform; - time to market of new technologies; - adherence to industry standards; - ability...
ibit access to care for enrollees. Subsequent regulations relevant to the EHB have continued the benchmark plan approach for 2016 and future years and have implemented clarifications and modifications to the existing EHB regulations, includin g the prohibition on discrimination, network adequacy standards and other req...
Agilent has signed an agreement to sell its healthcare solutions business unit to Philips, a deal expected to close in the first half of 2001. The business unit, which reported $1.4 billion in revenue for fiscal year 2000, operates in over 100 countries and provides patient monitoring, ultrasound imaging, and cardiolog...
Stanley Electronic Co., Ltd., Infineon and Toshiba. HEALTHCARE SOLUTIONS Our healthcare solutions business is a worldwide leader in electro-medical clinical measurement and diagnostic solutions. Our products and systems enable medical professionals to gather and analyze information in hospital intensive care units and...
n the Chicago Divestiture. Excluding the gain, noninterest income increased $35 million driven by an accounting change for low-income housing investments, which is offset in income tax expense. Noninterest expense in 2015 of $94 million decreased $133 million from 2014, reflecting lower restructuring charges and specia...
The company's chemical analysis business, which employed approximately 3,700 people as of October 31, 2000, generated $1.1 billion in revenue in fiscal year 2000, up from $1.0 billion in 1999 and $938 million in 1998. The company serves the hydrocarbon processing, environmental, and pharmaceutical markets, targeting a ...
et approval applications be submitted for our existing "Pre-Amendment" class III devices. Once clearance or approval is obtained, FDA oversight continues. We are required to demonstrate and maintain compliance with the Quality System Regulations for all our products. The FDA enforces the Quality System Regulations thro...
EX, are important to us and are generally covered by trademark applications or registrations in the USPTO and the patent or trademark offices of other countries. We also use trademarks licensed from third parties, such as the mark TYSABRI which we license from Elan. Trademark protection varies in accordance with local ...
Agilent reported R&D expenditures of $1,258 million in fiscal year 2000, $997 million in 1999, and $948 million in 1998. International net revenue accounted for approximately 55.8% of total net revenue in fiscal year 2000, with Japan contributing roughly 19% of that international revenue.
ration, Thermo Electron, Inc. and Waters. Our ability to compete effectively depends upon a number of factors including our ability to: - produce high-quality and reliable products; - introduce new technologies and products in a timely manner; - provide favorable overall cost of ownership; and - provide product and ser...
. Accordingly, direct subsidiaries of Ares Management, L.P. that are treated as corporations for U.S. federal income tax purposes and that are the holders of Ares Operating Group Units are (and, in the case of Ares Offshore Holdings, Ltd., may be) subject to U.S. federal, state and local income taxes in respect of thei...
The company operates 35 manufacturing sites and 196 million square feet of space worldwide, including headquarters in Palo Alto, California, and facilities in the U.S., China, Germany, Japan, Malaysia, Singapore, and the U.K. Key executives include Robert R. Walker as Executive Vice President and CFO, and Thomas A. Sap...
43, has served as our Senior Vice President, Healthcare Solutions since October 1999. Prior to assuming that position, Mr. Rusckowski held a number of positions at Hewlett-Packard. He served as General Manager of the Cardiology Products Division from 1997 to 1999, General Manager of the Healthcare Information Manageme...
bligations. Any such failure would have a material adverse effect on the Company. Guarantees of indebtedness not recorded on the Company’s consolidated balance sheets The following table summarizes the principal guarantees issued as of December 28, 2003 for which underlying liabilities are not recorded on the Company’s...
The company reported total net revenue of $10.8 billion in 2000, a 29.3% increase from 1999, driven by growth in the communications and electronics markets and increased demand in Asia. Net earnings rose to $757 million in 2000 from $512 million in 1999, while the company anticipates a $26 million cumulative after-tax ...
of our customers who often delay or accelerate purchases in reaction to variations in their businesses and in the economy. We expect some portions of our businesses to remain cyclical in the future. Given that a high proportion of our costs are fixed, variability in revenue as a result of these business cycles could di...
usiness with our existing business; • diversion of management resources and focus from ongoing business matters; • retention of key employees following the acquisition; • continued changes in the competitive environment, including recent announcements from competitors of new lower-priced scanners which we expect will l...
The semiconductor products business reported net revenue of $2.213 billion and operating earnings of $270 million in 2000, driven by growth in networking and imaging components despite a 40.3% increase in SG&A expenses. Conversely, the healthcare solutions business saw net revenue decline 5.9% to $1.412 billion in 2000...
ed overall operating expenses higher. Research and development expenses increased 23.8 percent in 2000 compared to 1999 and were unchanged in 1999 compared to 1998. The increase in 2000 reflects increased activity in new product development in the communications market. Selling, general and administrative expenses incr...
the Indenture agreement. 52 Table of Contents On August 1, 2001 we completed the sale of our healthcare solutions business to Phillips for initial proceeds of approximately $1.7 billion. In May of 2002 we finalized the sale agreement. We received $1.6 billion in August of 2001 and since then we have received all of the...
The company entered an agreement in Q1 2001 to sell its healthcare solutions business to Philips for approximately $1.7 billion and acquired OSI for $684 million in cash. It also plans to purchase the remaining 4.2% of Agilent Technologies Japan, Ltd's shares from Yokogawa by January 31, 2001, and anticipates selling i...
gies Japan, Ltd and several other companies. We expect to purchase the remaining 4.2% of Agilent Technologies Japan, Ltd's shares owned by Yokogawa prior to January 31, 2001. Hewlett-Packard provided the funding for the Yokogawa transaction in November 1999. Future sales of our portfolio of lease assets to CIT are anti...
Price and product competition in the communications and networking industries, which can change rapidly due to technological innovation and different business models from various geographic regions • The overall movement toward industry consolidation among both our competitors and our customers • The introduction and m...
In the fourth quarter of 2000, Agilent entered into a vendor financing agreement with The CIT Group, Inc. to provide equipment financing through a new subsidiary, Agilent Financial Services, Inc., and sold a portion of its U.S. lease assets to CIT for net proceeds of $234 million. Additionally, Agilent reported net ear...
the purchase price was allocated to tangible assets. Dispositions. In the fourth quarter of 2000, Agilent entered into a vendor financing agreement with The CIT Group, Inc. (CIT), whereby CIT will provide equipment financing and leasing services to Agilent's customers on a global basis. Under the terms of the agreement...
sites, including three former MGP sites. The investigations have revealed contamination related to the by-products of gas manufacturing at each MGP site. In addition to the MGP sites, DTE Electric is also in the process of cleaning up other contaminated sites, including the area surrounding an ash landfill, electrical ...
As of October 31, 2000, Agilent had 45,891,000 outstanding options with a weighted-average exercise price of $48, following the conversion of 17,667,000 Hewlett-Packard awards. Stock-based compensation expense for discounted options was $24 million in 2000, and pro forma adjustments for SFAS No. 123 would have reduced ...
ned in section 422 of the Internal Revenue Code, or non-statutory. Options generally vest at a rate of 25 percent per year over a period of four years from the date of grant. The exercise price for incentive stock options may not be less than 100 percent of the fair market value of the underlying Agilent stock on the d...
r value for these indemnification obligations was not material as of October 31, 2013 . Other Indemnifications As is customary in our industry and as provided for in local law in the U.S. and other jurisdictions, many of our standard contracts provide remedies to our customers and others with whom we enter into contrac...
Following the June 2, 2000, distribution of Agilent shares to Hewlett-Packard shareholders, Agilent reported net revenue of $341 million from sales to Hewlett-Packard for the period from November 1, 1999, through June 2, 2000. The companies entered into various separation agreements, including a Master Separation and D...
ed health care trend rates could have a significant effect on the amounts reported for health care plans. A one-percentage point change in the assumed health care cost trend rates for the year ended October 31, 2000 would have the following effects: 1 PERCENTAGE 1 PERCENTAGE POINT INCREASE POINT DECREASE --------------...
internal Non-U.S. Fund distributors, to third party distributors of our non-U.S. Funds. Other compensation may be offered to the extent not prohibited by federal or state laws or any self-regulatory agency, such as the Financial Industry Regulatory Authority (“FINRA”). FTDI makes payments for events it deems appropriat...
This exhibit index lists various agreements, including a Master Separation and Distribution Agreement, multiple technology and license agreements, and credit agreements between Hewlett-Packard and the Company. It also includes corporate documents such as the Certificate of Incorporation, Bylaws, and various employee st...
------------------------------ Walter B. Hewlett /s/ HEIDI KUNZ Director January 14, 2001 ----------------------------------------------------- Heidi Kunz /s/ DAVID M. LAWRENCE Director January 14, 2001 ----------------------------------------------------- David M. Lawrence, M.D. Director ------------------------------...
NANCIAL CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 162 Capital One Financial Corporation (COF) Table of Contents CAPITAL ONE FINANCIAL CORPORATION NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 163 Capital One Financial Corporation (COF) Table of Contents CAPITAL ONE FINANCIAL CORPORATION NOTES TO CONSOLIDATED ...
Agilent's test and measurement business provides automated test equipment and solutions for the wireless, semiconductor, and electronics industries, catering to original equipment manufacturers (OEMs), contract manufacturers (such as Solectron Corp. and Flextronics International), and service providers (including AT&T ...
eploy cellular base stations for these wireless networks. In addition, the rapid growth of the cellular handset market has created a new market segment for automated test equipment to test cellular handsets on the factory floor. Further, as new standards evolve in the wireless industry, new test and measurement equipme...
r executive officers. These key personnel have significant experience and skills in the homebuilding, lot development, financial services and rental housing industries, as well as leadership and management abilities that are vital to our success. Our ability to attract and retain our key personnel may be impacted by ma...
The semiconductor products business reported revenues of $1.9 billion in fiscal year 2001, $2.2 billion in 2000, and $1.7 billion in 1999, employing approximately 9,000 people as of October 31, 2001. The company serves the networking, mobile communication, and computing/printing markets, acting as a leading supplier of...
for our large accounts, and enhance our understanding of the future needs of these customers. Our systems engineers provide a combination of consulting, systems integration and application and software engineering services, and are instrumental in all stages of the sale, implementation and support of our complex syste...
of the sector and maturity distributions, refer to Note 3 to the Consolidated Financial Statements under Item 8. Regulation Our insurance and reinsurance subsidiaries conduct business globally, including in all 50 states of the United States, the District of Columbia, and all U.S. Territories. Our business is subject t...
The company provides analytical instrumentation for the chemical, environmental, pharmaceutical, and bioagriculture markets, offering products such as gas and liquid chromatographs and mass spectrometers. Its strategy focuses on targeting high-growth areas like gene expression and proteomics, expanding distribution in ...
tical instrumentation market. Primarily, our chemical analysis business serves the following markets: • chemical; • environmental; • pharmaceutical and biopharmaceutical; and • bioagriculture and foods. 14 Table of Contents Chemical Our chemical analysis business encompasses the natural gas, petroleum refining, petroch...
8,264 19,638 1,217,902 Segment selling, general, administrative and development expense 51,666 16,438 68,104 4,351 72,455 Segment operating profit $ 964,539 $ 165,621 $ 1,130,160 $ 15,287 1,145,447 Other selling, general, administrative and development expense $ 107,919 107,919 Depreciation, amortization and accretion ...
In fiscal year 2001, international net revenue accounted for approximately 59.8% of total net revenue, with Japan providing about 20% of that international portion, while long-lived assets outside the U.S. represented 43.7% of total long-lived assets. The company recorded approximately $459 million in inventory-related...
tive advantage. While we believe that our patents and applications have value, in general no single patent is in itself essential. In addition, we cannot assure you that any of our proprietary rights will not be challenged, invalidated or circumvented, or that our rights will provide significant competitive advantages....
was proposed to transport onshore gas production from the Mackenzie Delta in northern Canada to established markets in North America. We have a 75 percent interest in the Parsons Lake natural gas field, one of the primary fields in the Mackenzie Delta, which would anchor the pipeline development. Due to a continued dec...
The company reported an after-tax gain of $646 million from the sale of its healthcare solutions business to Philips, while also recognizing a $350 million restructuring charge to reduce its workforce by approximately 8,000 employees by mid-2002. Significant acquisitions during 1999-2001 included Objective Systems Inte...
lemented by the Amendment and Supplemental Agreement, dated as of August 1, 2001. The total purchase price is subject to adjustment based on the determination of the final purchased net assets and on our performance of certain services for Philips. Since August 1, 2001 we have received approximately $80 million of the ...
s based upon our operating results for each taxable jurisdiction in which we operate and the amount of statutory tax that we incur in each jurisdiction. We exercised significant judgment in regards to estimates of future market growth, forecasted earnings and projected taxable income, in determining the provision for i...
The company's test and measurement business reported a 11.1% decrease in net revenue to $5,432 million in 2001 due to a slowdown in the telecommunications and semiconductor industries, resulting in an operating loss of $141 million. The semiconductor products business saw a 16.4% revenue decline to $1,850 million in 20...
tructuring charges. These items have been excluded for all periods presented. Test and Measurement Our test and measurement business provides test instruments, standard and customized test, measurement and monitoring instruments and systems for the design, manufacture and support of electronics and communications devic...
erson (and such person's affiliates and associates) that is the owner of 15% or more (a "15% Holder") of our outstanding voting shares) shall be required for various corporate actions, including: • merger or consolidation of the company into a 15% Holder; • sale of any or all of our assets to a 15% Holder; • the issuan...
The company faces risks from inventory-related charges, such as the $459 million charge incurred in the year ended October 31, 2001, due to non-cancelable purchase commitments and declining demand. Additionally, the company faces operational risks from legacy system transitions, international trade volatility, and the ...
s could adversely affect our earnings. Our earnings could be harmed if we are unable to adjust our orders for parts to market fluctuations. In order to secure components for the production of products, we may enter into non-cancelable purchase commitments with vendors, or at times make advance payments to suppliers, wh...
the acquisition of Snyder’s-Lance. Total consideration was $6.112 billion , which included the payoff of approximately $1.1 billion of Snyder's-Lance indebtedness. We borrowed $900 million under a single draw 3-year senior unsecured term loan facility on March 26, 2018, and issued $5.3 billion senior notes on March 16,...
Agilent Technologies, Inc. reported net earnings of $174 million for the fiscal year ended October 31, 2001, impacted by a $47 million net charge for adopting SAB 101 and a $25 million net charge for adopting SFAS No. 133. Key financial activities included the acquisition of Yokogawa's 4.2% interest in Agilent Technolo...
an, Ltd. shares from Yokogawa for approximately $216 million. In January 2001, Agilent completed its acquisition of Yokogawa’s 25 percent equity interest in Agilent Technologies Japan, Ltd. by purchasing the remaining 4.2 percent interest for approximately 60 Table of Contents AGILENT TECHNOLOGIES, INC. NOTES TO CONSOL...
Agilent's customers across a number of product lines and provide the same level of service and support expected from our direct channel. Lower dollar transactions can also be served by our tele-sales and electronic commerce channels. Our products typically come with three year standard warranties, and extended warranti...
Agilent Technologies reported stock-based compensation expenses of $8 million in 2001, $24 million in 2000, and $39 million in 1999 (allocated from HP), while maintaining various plans including the Legacy Plan, the Agilent 423(b) Plan, and the 1999 Stock Plan. As of October 31, 2001, the company had 63,656,000 outstan...
years. After February 2, 2000, Agilent implemented the Agilent Technologies, Inc. Employee Stock Purchase Plan (the “Legacy Plan”) that was similar to the HP Plan and allowed eligible employees to contribute up to ten percent of their base compensation to the purchase of Agilent common stock. Under the provisions of t...
esponsibilities for compliance in reserves bookings to our Reserve Evaluation Group (the “Group”). These same policies also require that reserve estimates be made by professionally qualified reserves estimators, as defined by the Society of Petroleum Engineers’ standards. The Group, which is led by Devon’s Director of ...
As of October 31, 2001, Agilent Technologies reported a net prepaid (accrued) cost of $(114) million for non-U.S. defined benefit plans and $107 million for U.S. defined benefit plans. The company also reported $169 million in non-current retirement benefit liabilities and maintained two revolving credit facilities tot...
ants’ contributions — — 8 7 4 5 Change in population estimate — 16 — 8 — 15 Benefits paid (41 ) (23 ) (10 ) (10 ) (11 ) (10 ) Currency impact — — (9 ) (87 ) — — Divestiture of Healthcare Solutions Business — — (60 ) — — — Other — — 14 — — — Fair value — end of year $ 451 $ 655 $ 746 $ 807 $ 311 $ 426 Change in benefit ...
c., effective as of August 12, 1999. S-1/A 11/10/1999 2.1 2.2 General Assignment and Assumption Agreement between Hewlett‑Packard and Agilent Technologies, Inc. S-1/A 11/10/1999 2.2 2.3 Master Technology Ownership and License Agreement between Hewlett‑Packard and Agilent Technologies, Inc. S-1/A 11/10/1999 2.3 2.4 Mast...
For the fiscal year ended October 31, 2002, the company reported total net revenue of $6.0 billion, with the Test and Measurement segment contributing $3.3 billion (approximately 55% of total revenue). The company employed 36,000 people worldwide and maintained significant R&D and manufacturing sites across the U.S., C...
tronic commerce. Of our total net revenue of $6.0 billion in the fiscal year ended October 31, 2002, we generated 39 percent in the United States (“U.S.”) and 61 percent internationally. As of October 31, 2002, we employed approximately 36,000 people worldwide. We have major research and development (“R&D”) and manufac...
he various impacts of the Tax Act below. SEC Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (which we refer to as SAB 118) describes three scenarios associated with a company’s status of accounting for income tax reform. Under the SAB 118 guidance, we made reasonable ...
The company provides a wide range of test and measurement solutions, including communication monitoring systems, general-purpose instruments, modular test software, and automated optical/x-ray/in-circuit inspection systems for electronics manufacturing. Key product offerings include semiconductor test equipment for fla...
mmission, and activate networks and services more quickly. For example, our 10-Gigabit Field Transmission Test Set enables technicians to test 192 fiber optic channels simultaneously. Also, our standards-based unification platform allows simplification of operation support and systems by reducing the software integrati...
es with low sales volumes, sales are made through various representatives and distributors. However, we also sell into international markets directly from the U.S. Our international business is subject to risks customarily encountered in foreign operations, including interruption to transportation flows for delivery of...
The company produces a diverse range of semiconductor products, including DWDM optical transport ICs, RF/microwave communications (FBAR and E-pHEMT), and printer ASICs, with Hewlett-Packard accounting for approximately 33% of semiconductor revenue in fiscal year 2002. Additionally, the company operates a life sciences ...
are developing transmission and switching products for dense wave division multiplexing (“DWDM”) optical transport applications. High-Speed Digital Integrated Circuits. We produce physical layer ICs for high speed network switches and routers, devices that direct network traffic. We produce Fibre Channel protocol-based...
which the interest rate on a portion of this debt was effectively fixed through an interest rate swap agreement through the maturity of the swap in early June 2010. Concurrent with the maturity of the interest rate swap, we executed an interest rate cap limiting the maximum interest rate paid on the portion of the debt...
Agilent expanded its life sciences and chemical analysis portfolio in 2002 by introducing products such as the 3000 Micro GC, the 1100 Series LC/MS system, and the Cerity Pharmaceutical Networked Data System. The company serves approximately 25,000 customers, with its top 25 customers accounting for approximately 22% o...
ns. For example, we have formed and expanded relationships with Incyte Genomics for microarray content and with Rosetta Inpharmatics, Inc. for microarray analysis software. In addition, we develop our products with a commitment to open platforms and industry standards in order to work with our partners’ products, enabl...
11.5 15.4 10.6 Healthcare 12.0 11.8 14.1 10.9 Industrials 11.8 10.7 11.7 11.0 Consumer discretionary 9.4 10.7 8.3 10.6 Financial 8.5 13.4 11.7 16.1 Materials 5.7 3.5 5.2 3.7 Utilities 5.5 3.9 4.2 3.3 Telecomm services 3.9 3.2 3.5 3.1 Total 100.0 % 100.0 % 100.0 % 100.0 % Preferred Stocks We evaluate preferred stocks in...
The company reported international net revenue of approximately 61% in fiscal 2002, with 11% of international revenue derived from Japan, while long-lived assets outside the U.S. accounted for approximately 62% of total long-lived assets in the same period. Significant historical acquisitions include Objective Systems ...
me custom work where it may be cost prohibitive to have multiple suppliers. Our long-term relationships with our suppliers allow us to proactively manage technology road maps and product discontinuance plans and monitor their financial health. Even so, some suppliers may still extend their lead times, limit supplies, i...
“Item 1. Business - Regulation and Legislation.” Various events could disrupt or result in unauthorized access to our networks, information systems or properties and could impair our operating activities and negatively impact our reputation and financial results. Network and information systems technologies are critica...
Agilent Technologies reported a net loss of $1.032 billion for the fiscal year ended October 31, 2002, on net revenue of $6.010 billion, which included a $474 million pre-tax restructuring charge. The company is currently defending a securities class action (Kassin v. Agilent Technologies, Inc.) regarding its IPO and m...
offices throughout the world. Life Sciences and Chemical Analysis. Our life sciences and chemical analysis business has manufacturing facilities in California and Delaware in the U.S., China, Germany and Japan. We have marketing centers in Germany, Singapore and the U.S., and sales offices throughout the world. 26 Tabl...
to Exhibit (10) of our Form 8-K dated May 14, 2007. (iii) Increase of Commitments Agreement dated as of October 29, 2007 by and among Ecolab Inc., Citibank, N.A., JPMorgan Chase Bank, N.A., Credit Suisse, Cayman Islands Branch, National Association, Wells Fargo Bank, National Association, ABN AMRO Bank N.A., Bank of Am...
The company reported a $1,607 million loss in 2002, down from a $778 million loss in 2001, as total net revenue fell 28% to $6,010 million due to weakness in the telecommunications and semiconductor markets. To mitigate these losses, the company implemented restructuring plans resulting in $880 million in savings and a...
2001 and 2000. Gross proceeds from these dispositions were $31 million in 2002, $13 million in 2001 and insignificant in 2000. Gains from the dispositions, included in other income (expense), net, in the consolidated statement of operations, were $15 million in 2002, $9 million in 2001 and insignificant in 2000. Sale o...
) Amortization of net prior service cost (benefit) $ — $ — $ (9 ) Amortization of actuarial net loss (gain) $ 3 $ 35 $ 11 Investment policies and strategies as of October 31, 2016 and 2015 . In the U.S., target asset allocations for our retirement and post-retirement benefit plans are approximately 80 percent to equiti...
In 2002, the company reported a net revenue of $1,559 million and a loss from operations of $68 million, reflecting a 16% revenue decline from 2001 and a 62% improvement in operating margin. The company achieved approximately $600 million in savings from the 2001 Plan, including an 11% headcount reduction, while target...
ines or stagnation of the last several quarters, while reductions have been targeted to products in markets that are particularly weak and not expected to recover in the near term, such as wireline telecommunications. The increase in research and development expenses as a percentage of net revenue in 2001 compared to 2...
prices of these commodities could increase the costs of our products and services, and we may not be able to pass on these costs to our customers. We do not currently use financial derivatives to hedge against this volatility, however, we utilize firm purchase commitments to mitigate risk. The pricing of some commoditi...
The company reported cash and cash equivalents of $1,844 million as of October 31, 2002, following a period of significant restructuring and cost-reduction measures that included $235 million in severance payments. Financial highlights include an after-tax gain of $646 million from the sale of its discontinued healthca...
eductions contributed approximately $20 million to our bottom line for the year. The increase in earnings from operations in 2001 compared to 2000 was primarily due to higher net 50 Table of Contents revenue and reduced spending resulting from our cost reduction measures. In addition, operational efficiencies arising o...
nts included in Part II, Item 8 — Financial Statements and Supplementary Data, included elsewhere in this report. During the year ended December 31, 2014 , the quality of the commercial loan portfolio improved. As of December 31, 2014 , total criticized loans decreased to 4.5% , or $1.9 billion , of the commercial loan...
The company faces risks from excess manufacturing capacity, non-cancelable purchase commitments—which led to $459 million in inventory charges in 2001 and $40 million in 2002—and potential operational disruptions during the implementation of new enterprise resource planning software. Additionally, the company's results...
ich we compete. Each of the above measures could have long-term effects on our business by reducing our pool of technical talent, decreasing or slowing improvements in our products, making it more difficult for us to respond to customers, limiting our ability to increase production quickly if and when the demand for ou...
6 versus 2005, and 2005 versus 2004. Years Ended October 31, 2006 over 2005 Change 2005 over 2004 Change 2006 2005 2004 Total gross margin 52 % 50 % 48 % 2 ppts 2 ppts Operating margin 15 % 14 % 14 % 1 ppt — Research and development $ 143 $ 136 $ 117 5% 16% Selling, general and administrative $ 430 $ 377 $ 342 14% 10% ...
The company faces significant risks from non-compliance with complex international, federal, and state regulations regarding environmental protection, health and safety, and government contracts, where U.S. government sales account for approximately 5 percent of total sales. Additionally, the company faces potential li...
manufacturing processes involve the use of substances regulated under various international, federal, state and local laws governing the environment. We may be subject to liabilities for environmental contamination, and these liabilities may be substantial. Although our policy is to apply strict standards for environm...
ts. The increase in total cost of sales as a percentage of total net sales was primarily attributable to non-recurring expenses related to the Company's data migration to a new cloud-storage provider. Cost of product and service sales was $97.7 million and $69.2 million for the years ended December 31, 2016 and 2015, r...
Agilent Technologies, Inc. reported a net loss of $1,032 million for the fiscal year ended October 31, 2002, and disclosed significant accounting adjustments including a $47 million net charge for SAB 101 adoption and a $25 million after-tax reduction for SFAS No. 133. The company also reported total property, plant, a...
ur customers on a global basis. This agreement has been in place since the fourth quarter of 2000. In addition to the CIT Group Sale and the sale of the healthcare solutions business, we sold assets related to portions of our businesses to third parties during 2002, 2001, and 2000. Gross proceeds from these disposition...
o AndroGel and Creon, to AbbVie's portfolio. Generic competition began in November 2012 for TriCor and is expected to begin in the second half of 2013 for Niaspan and in the second half of 2013 or early 2014 for TRILIPIX. As a result, sales for AbbVie's combined lipid franchise including TriCor, TRILIPIX, Niaspan and S...
Agilent Technologies, Inc. reported total restructuring and asset impairment charges of $474 million for the year ended October 31, 2002, driven by the 2001 Plan ($511 million in cumulative expenses through October 31, 2002) and the 2002 Plan, which aimed to reduce quarterly operational costs by $50 million. Key activi...
e are exiting office space housing sales and administrative employees. However, a small number of production facilities were closed as a result of our plans to consolidate manufacturing into fewer sites. Asset impairment charges relate to fixed assets and were determined using estimates of the expected future cash flow...
marily on final assembly and test of our products. To maximize our productivity and our ability to respond to market conditions, we use contract manufacturers for the production of printed circuit boards, sheet metal fabrication, metal die-casting, plastic molding and standard electronic components. We also manufacture...
Agilent Technologies reported total net plan costs of $105 million for 2002, driven by U.S. pension and post-retirement benefit costs of $99 million and non-U.S. costs of $6 million. As of October 31, 2002, the fair value of U.S. plan assets was $407 million against a benefit obligation of $761 million, while non-U.S. ...
g lifetime or total number of participants in our retirement and postretirement plans. The restructuring program and the sale of our healthcare solutions business described above both resulted in material changes to our plan demographics in the U.S. and several other countries. The curtailment and settlement gains and ...
r existing businesses in communications, life sciences, and electronics, and 2) research that creates new businesses that are outside of our current markets but within our fields of interest. Agilent Labs also provides technology integration across our company. 20 Table of Contents Index to Financial Statements Agilent...
Agilent Technologies reported total net revenue of $6,010 million for the fiscal year ended October 31, 2002, with a reported loss from continuing operations before taxes of $1,547 million. The company operates three reportable segments—Test and Measurement, Semiconductor Products, and Life Sciences and Chemical Analys...
us to pay property taxes, insurance and routine maintenance, and include escalation clauses. Rent expense was $177 million in 2002, $100 million in 2001 and $69 million in 2000. 19. Contingencies We are involved in lawsuits, claims, investigations and proceedings, including patent, commercial and environmental matters ...
Our solutions for public companies include transactional and compliance reporting services to public companies, including document composition, SEC filing services for capital markets transactions such as initial public offerings, spin-offs, acquisitions, and debt and equity securities offerings, and year-round SEC dis...
Agilent's test and measurement business, which employed approximately 11,900 people as of October 31, 2003, generated revenue of $2.5 billion in fiscal 2003, $2.6 billion in fiscal 2002, and $4.5 billion in fiscal 2001. The segment serves customers in over 110 countries providing solutions for communications test and g...
ures include items sold to contract manufacturers who manufacture products on Hewlett-Packard’s behalf. Test and Measurement Our test and measurement business provides standard and customized solutions that are used in the design, development, manufacture, installation, deployment and operation of electronic equipment ...
jury coverage development, offset by strengthening in our homeowners lines. Auto liability claims process changes implemented in prior years, including a program requiring enhanced documentation of injuries and related medical treatments, resulted in favorable severity trends compared to those originally estimated as w...
Agilent's automated test business, which employed approximately 2,300 people as of October 31, 2003, generated $0.8 billion in revenue in fiscal 2003, up from $0.7 billion in fiscal 2002 and $0.9 billion in fiscal 2001. The company utilizes a direct sales force of field and systems engineers, alongside value-added rese...
omer satisfaction. Our direct sales force is focused on identifying customer needs and recommending solutions involving the effective use and deployment of our equipment, services, systems and capabilities. Some members of our direct sales force focus on global accounts, providing uniform services on a worldwide basis....
of Directors and the stockholders, respectively, approved the reservation of an additional 25 million shares of common stock under the 2018 Plan. The 2018 Plan provides for awards of stock-based incentive compensation to our employees (including officers) and directors. The 2018 Plan provides for the grant of awards in...
The company is a leading supplier of fiber optic transceivers, high-speed digital ICs (including Fibre Channel controllers), and RF/microwave products like FBAR duplexers and E-pHEMT power amplifiers for networking and mobile systems. It also provides printing ASICs for Hewlett-Packard, infrared products, and is a join...
1 Table of Contents Index to Financial Statements driven by the ongoing growth of data traffic. Business-to-consumer and business-to-business e-commerce, the internet, the growing volume of e-mail traffic, the growth of streaming video and audio, the delivery of online services, and peer-to-peer communications are all ...
f service may retire early from age 55 to 64. An early retirement factor is applied resulting in a reduced benefit. If an employee terminates with less than 5 years of service, such employee forfeits the right to receive any pension benefits accumulated to that time. Annual funding requirements are determined based on ...
Agilent Technologies provides gas/liquid chromatography and mass spectrometry solutions for the petrochemical, homeland security, and life sciences markets, including the launch of the 6820 GC for China and the 1100 Series LC/MSD Trap XCT. The company also offers microarray and microfluidics solutions, notably the 2100...
, the industrial and manufacturing sectors, engineering and consulting companies, commercial testing laboratories and colleges and universities. We are seeing increased international demand for environmental instrumentation in the Asia-Pacific region. Petrochemical. The natural gas and petroleum refining markets use ou...
g ending the production of track drills; pursuing strategic alternatives, including the possible divestiture of room and pillar products; consolidation of two product development divisions; and additional actions in response to ongoing weakness in the mining industry. We estimate restructuring costs incurred under thes...
Agilent Labs employs approximately 300 people, 70% of whom are technical staff with advanced degrees. The company reported R&D expenditures of $1,051 million in 2003, $1,250 million in 2002, and $1,358 million in 2001, while international net revenue accounted for approximately 64% of total net revenue in fiscal 2003.
r existing businesses in communications, life sciences, and electronics, and 2) research that creates new businesses that are outside of our current markets but within our fields of interest. Agilent Labs also provides technology integration across our company. 20 Table of Contents Index to Financial Statements Agilent...
ame line item as the offsetting loss or gain on the hedged item in the Consolidated Statements of Operations. Additionally, the Duke Energy Registrants’ enter into derivative agreements that are economic hedges that either do not qualify for hedge accounting or have not been designated as a hedge. The changes in fair v...
The company implemented a multi-year restructuring strategy (2001, 2002, and 2003 Plans) to reduce costs, resulting in $526 million in total charges through October 31, 2003, and an estimated quarterly savings of $350 million. Key actions included reducing the workforce by over 10,900 employees, consolidating more than...
9,000 employees. Our plans to consolidate excess facilities resulted in charges for lease termination fees and losses anticipated from sub-lease agreements. We have exited, or plan to exit in the near future, more than 110 production, support and sales facilities in the U.S., Korea, Japan, U.K. and other countries, rep...
other employee stock plans 4 5 8 Diluted weighted average shares 345 353 355 The dilutive effect of share-based awards is reflected in diluted net income per share by application of the treasury stock method, which includes consideration of unamortized share-based compensation expense, the tax benefits or shortfalls ch...
The company reported an after-tax gain of $646 million in 2001 and an after-tax loss of $10 million in 2002 from the sale of its healthcare solutions business to Philips, which was classified as a discontinued operation. Additionally, the company sold its leasing portfolio to CIT Group Inc. (generating $287 million in ...
er payments following pursuant to the terms of the Asset Purchase Agreement dated as of November 17, 2000, as amended and supplemented by the Amendment and Supplemental Agreement, dated as of August 1, 2001 (collectively, the “Asset Purchase Agreement”). The total purchase price was subject to adjustment based on the d...
losses added 9.7 percentage points in 2019, 9.1 points in 2018 and 11.2 points in 2017 to the respective personal lines current accident year loss and loss expense ratios in the table above. Personal lines catastrophe losses for 2019 resulted in a ratio lower than our 10.9% 10-year annual average for personal lines tha...
In 2003, the company reported a loss from operations of $725 million, a decrease from 2002 primarily driven by $326 million in reduced goodwill amortization/impairments and $160 million in indirect expense savings. The company also recorded a $1.0 billion net tax provision in 2003 to establish a valuation allowance on ...
rom operations $ (725 ) $ (1,607 ) $ (778 ) 55% (107)% Operating (deficit) margin (12 )% (27 )% (9 )% 15 points (18) points The loss from operations in 2003 was $725 million, a decrease of approximately $882 million. The decrease was primarily due to a decrease in goodwill amortization and impairments of $326 million, ...
clauses. Total rent expense was $57 million in 2017 , $61 million in 2016 and $65 million in 2015 . Contingencies: We are involved in lawsuits, claims, investigations and proceedings, including, but not limited to, patent, commercial and environmental matters, which arise in the ordinary course of business. There are n...
The company reported a 7% increase in total net revenue to $885 million for fiscal year 2003, with orders rising 13% to $845 million driven by strength in the semiconductor test market. The company also reported a 51% improvement in loss from operations, narrowing to $34 million as the automated test segment achieved i...
n the manufacture of semiconductor devices and printed circuit assemblies. Our test solutions enable electronics designers and manufacturers to reduce the design to production cycle, lower manufacturing cost of test, confirm the functional quality of their devices and of their manufacturing processes, and accelerate th...
y standards, customer disclosures and auditing and examination programs for FCMs. The rules are intended to afford greater assurances to market participants that customer segregated funds and secured amounts are protected, customers are provided with appropriate notice of the risks of futures trading and of the FCMs wi...
In 2003, the company reported a total net revenue of $1,186 million (up 5% from 2002) and an operating income of $148 million, with restructuring savings totaling approximately $400 million. The life sciences and chemical analysis business saw a 2% increase in orders and a 4% increase in product net revenue, driven by ...
e headcount by 13 percent per year compared to 2002 and 2001, respectively. Overall savings from restructuring in 2003 totaled about $400 million for the full year and in 2002 totaled $250 million for the full year. Cost of products as a percentage of net revenue increased slightly in 2003 compared to 2002, as restruct...
U.S. commercial $ 566 $ 541 $ — $ 668 $ 650 $ — Commercial real estate 82 77 — 60 48 — Non-U.S. commercial 4 4 — — — — With an allowance recorded U.S. commercial $ 1,350 $ 1,157 $ 115 $ 1,139 $ 839 $ 75 Commercial real estate 328 107 11 678 495 48 Non-U.S. commercial 531 381 56 47 44 1 U.S. small business commercial (1...
The company is implementing new enterprise resource planning and information systems to replace legacy Hewlett-Packard systems, experiencing operational difficulties in quoting and shipping orders during the initial phase. Risks to financial results include excess manufacturing capacity due to low demand in the communi...
ience additional excess and obsolete inventories and be forced to incur additional charges. We are continuing to implement new information systems, and problems with the design or implementation of these new systems have interfered and could further interfere with our operations. We are in the process of implementing n...
’s inception date is September 1990. The BPS Composite includes only BAAM-managed commingled and customized multi-manager funds and accounts. None of the other platforms/strategies managed through the Blackstone Hedge Fund Solutions Group are included in the composite (except for investments by BPS funds/accounts direc...
The company faces risks from non-compliance with government contract regulations, potential intellectual property litigation, and the limitations of its current patent cross-license agreement with Hewlett-Packard. Additionally, the company's financial results may be impacted by the complexities of integrating acquisiti...
could be made to pay civil penalties, face criminal prosecution and, in some cases, be prohibited from distributing our products in commerce until the products or component substances are brought into compliance. We are subject to laws and regulations governing government contracts, and failure to address these laws an...
of electronics equipment, and microscopy products. Related services include start-up assistance, instrument productivity and application services and instrument calibration and repair. We also offer customization, consulting and optimization services throughout the customer's product lifecycle. 46 Table of Contents Ord...
As of October 31, 2003, Agilent Technologies, Inc. had 75,861,602 shares registered for option and restricted stock grants, with 51,366,000 options outstanding and 26,141,000 options exercisable. The company reported compensation expenses of $6 million, $7 million, and $8 million for 2003, 2002, and 2001 respectively, ...
d by the 423(b) Plan. As of October 31, 2003, 38,860,247 shares of our common stock were authorized for issuance under the 423(b) Plan and 13,636,414 of these shares have been issued. Incentive compensation plans. On September 17, 1999, we adopted the Agilent Technologies, Inc. 1999 Stock Plan (the “Stock Plan”) and su...
the $25 million raised floodwall project at New Jersey’s Raritan Millstone Water Treatment Plant which provides protection against a 500 year flood, and the $15 million Bel Air, Maryland Reservoir project which provides 90 million gallons of drought mitigation water storage for the region. Regulation and Rate Making Th...
Agilent Technologies reported inventory of $995 million and net property, plant, and equipment of $1,447 million as of October 31, 2003, while recording $11 million in inventory-related charges for the year. The company also reported $388 million in goodwill, recognized a $10 million impairment charge on intangible ass...
ares were dilutive, then this amount would be added back to loss from operations, and approximately 36 million of shares would be added to the weighted average number of shares for the purposes of calculating diluted income per share. See Note 17, “Senior Convertible Debentures and Lines of Credit.” 9. Supplemental Cas...
the basis of product performance, reliability, support quality, applications expertise, global channel coverage and price. Life Sciences and Diagnostics Government Regulation Some of the products the life sciences and diagnostics group sells are subject to regulatory approval by the FDA and other regulatory bodies thro...
Agilent Technologies reported total restructuring and asset impairment charges of $372 million for the fiscal year ended October 31, 2003, driven by three primary plans: the 2001 Plan ($308 million cost), the 2002 Plan ($166 million cost), and the 2003 Plan ($308 million cost). As of October 31, 2003, the company maint...
of some of the lease terms and the uncertainty of the real estate market, we expect to make periodic adjustments to the accrual balance to reflect changes in our estimates, and to reflect actual events as they occur. The cost of the 2001 Plan through October 31, 2003 was $526 million; $154 million in 2001, $357 millio...
iration of patent protection for the product; • our tenants with marketable products may be adversely affected by healthcare reform and the reimbursement policies of government or private healthcare payors; • our tenants with marketable products may be unable to successfully manufacture their drugs economically; • our ...
As of October 31, 2003, Agilent Technologies, Inc. reported $311 million in other accrued liabilities and $417 million in other long-term liabilities, including $285 million for retirement plans. The company also maintains $1.15 billion in senior convertible debentures due in 2021 and reported future minimum lease paym...
d) 16. Other Accrued Liabilities Other accrued liabilities and other long-term liabilities at October 31, 2003 and 2002 were as follows: October 31, 2003 2002 (in millions) Other accrued liabilities Accrued expenses $ 114 $ 108 Restructuring 89 148 Warranty accruals 57 59 Lease guarantees 31 68 Other 20 20 Total other ...
ember 31 (Dollars in millions) 2011 2010 2011 2010 2011 2010 Unconsolidated VIEs Maximum loss exposure $ 31,140 $ 20,320 $ 3,752 $ 4,261 $ 93 $ 141 On-balance sheet assets Senior securities held (1, 2) : Trading account assets $ 2,595 $ 1,219 $ 228 $ 255 $ — $ — AFS debt securities 27,616 17,989 — — 81 109 Subordinate ...
This exhibit index lists various corporate documents, including Change of Control Severance Agreements for multiple executives, the Agilent Technologies, Inc. 1999 Stock Plan and its amendments, and a lease with Shanghai WaiGaoQiao Free Trade Zone Dev. Co. Ltd. It also references Sarbanes-Oxley Act certifications, powe...
2. Incorporated by reference from Exhibit 10.17 of the Company’s Form 10-Q filed June 5, 2002. 10.15 Form of Change of Control Severance Agreement entered into by the Company with Byron J. Anderson, Dick M. Chang, Adrian T. Dillon, Jean M. Halloran, D. Craig Nordlund, Young K. Sohn, William P. Sullivan, Jack P. Trautma...
diesel, natural gas, gasoline and alternative-fuel electrical generator sets for use in RVs, commercial vehicles, recreational marine applications and home stand-by or residential applications. This segment continuously explores emerging technologies, such as fuel cells, wind and hybrid solutions and provides integrate...
Agilent offers test and measurement products ranging from sub-$1,000 devices to large-scale systems priced at $1 million or more, categorized into communications test products (fiber optics, transport networks, broadband, and wireless) and general purpose test products (instruments, modular software, digital design pro...
-unit electronic measurement devices priced under $1,000 to large scale test systems or OSS solutions priced at $1 million and higher. We divide our test and measurement products into two groups: (1) communications test products and (2) general purpose test products. Communications Test Products We sell installation an...
trict Court for the Eastern District of Michigan ("District Court") for further proceedings, including rulings on the facts surrounding specific claims and consideration of any equitable factors that would preclude the application of the Interest Rate Presumption. On May 10, 2017, the District Court entered a stipulate...
The company's automated test business designs and manufactures semiconductor, electronics manufacturing, and TFT array test equipment, featuring products like the 93000 SOC system and V5400 memory tester. As of the end of fiscal 2004, no single customer represented more than 10% of the business's net revenue, and the c...
nufacturing process, regardless of the FPD technology being used. Automated Test Products Our automated test business designs, develops and manufactures semiconductor test equipment, electronics manufacturing test equipment and TFT array test equipment. We typically develop our automated test products on a single syste...
ng. The large size of the positions which the Fund may acquire increases the risk of illiquidity by both making its positions more difficult to liquidate and increasing the losses incurred while trying to do so. The financing available to market participants from their banks, dealers and other counterparties is typical...
The company operates a semiconductor business serving networking and personal systems markets, including optical transceivers and high-speed digital ICs, and a life sciences and chemical analysis business that generated $1.3 billion in revenue in fiscal 2004. Key financial highlights include Hewlett-Packard accounting ...
ic transceivers, which convert electronic digital data into light signals for transmission, and convert light signals back into 14 Table of Contents electronic digital form on the receiving end of the communication. We market optical transceivers, transmitters and receivers for high-speed data communications for Fast, ...
nouncements to their derivative financial instruments. The Companies use derivative financial instruments to hedge market price fluctuations in related underlying transactions for the physical purchase and sale of electricity and gas and interest rate risk on certain debt securities. The Utilities are permitted by thei...
In 2004, Agilent expanded its mass spectrometry and software portfolios by introducing high-sensitivity instruments like the 7500ce ICP-MS, acquiring Silicon Genetics, and partnering on an $11.7 million NIST grant. The life sciences and chemical analysis business serves approximately 21,000 customers, with the top 25 a...
eins and other biological entities that undergo transformations because it enables the understanding and characterization of their many different states. MS systems are typically used in combination with gas or liquid chromatographs. In the past three years, Agilent significantly expanded its mass spectrometry portfoli...
focus include fostering a high-performance and inclusive culture built on strong leadership and highly engaged employees, building a pipeline of skilled workers and ensuring knowledge transfer as employees retire. Our Board of Directors provides oversight on certain human capital management matters, primarily through t...
Agilent reports that international net revenue was 69% in fiscal 2004, while long-lived assets outside the U.S. accounted for 53% of total long-lived assets. The company also disclosed the acquisition of Objective Systems Integrators for $716 million and a 25% equity interest in Agilent Technologies Japan for $521 mill...
of these properties are undergoing remediation by Hewlett-Packard under an order of an agency of the state in which the property is located. Although Hewlett-Packard has agreed to indemnify us with respect to that subsurface contamination, it is possible that one or more of the governmental agencies will require us to ...
process payments made by consumers, and if we cannot manage our relationship with such third parties and other related risks, our business, financial condition, and results of operations could be adversely affected. We primarily rely on a third-party payment processor, Stripe, to process payments made to merchants and ...
For the fiscal year ended October 31, 2004, the company reported an operating income of $386 million, a 153% increase over 2003, driven by $1,125 million in revenue growth and $474 million in incremental restructuring savings. Key financial highlights include a decrease in SG&A expenses due to $326 million in lower goo...
llion related to our ongoing restructuring cost savings. The decline was also driven in part by the decrease in indirect spending. The remainder of the decrease reflects our efforts in reducing our infrastructure costs and initiatives to control discretionary spending. Selling, general and administrative expenses as a ...
first six months of 2003 resulting in approximately $1.0 billion net tax provision recorded within provision for taxes for 2003; the valuation allowance essentially eliminated our net deferred tax assets. During the fourth quarter of 2003, we maintained a full valuation allowance on our net deferred tax assets in the i...
The company's automated test segment reported total net revenue of $924 million in 2004, a 22% increase over 2003, and achieved an operating profit of $66 million compared to a $34 million loss in 2003. While semiconductor test orders fell 6% in 2004 due to customer inventory and new product transitions, the segment im...
(primarily printed circuit-board assemblies) and flat panel displays. Our test solutions enable electronics designers and manufacturers to shorten the design-to-production cycle, lower manufacturing cost of test, confirm the functional quality of their devices and of their manufacturing processes, and accelerate the h...
evelopment, including through expansion into new international markets. During the year ended December 31, 2008, we grew our communications site portfolio through acquisitions and construction activities, including the acquisition of 269 towers for an aggregate purchase price of $42.8 million, and the construction of 6...
Agilent reports that while life sciences and chemical analysis markets have stabilized, semiconductor test and product revenues remain volatile and subject to intense pricing pressures. The company is pursuing a reduced cost structure through workforce reductions and outsourcing, while noting that new accounting standa...
educed demand for our products and services in many of the markets that we serve worldwide, as was the case in semiconductor test and semiconductor products. Revenues in the semiconductor test and semiconductor products businesses fluctuated significantly over the past three years. However, other markets we serve have ...
areholders, CERC had guaranteed certain contractual obligations of what became RRI’s trading subsidiary. When the companies separated, RRI agreed to secure CERC against obligations under the guaranties RRI had been unable to extinguish by the time of separation. Pursuant to such agreement, as amended in December 2007, ...
Agilent Technologies reported a net income of $349 million for 2004, a significant recovery from net losses of $2,058 million in 2003 and $1,032 million in 2002. The company reported total inventory of $1,026 million and net property, plant, and equipment of $1,258 million as of October 31, 2004.
ted options, stock appreciation rights and restricted 90 Table of Contents AGILENT TECHNOLOGIES, INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) stock is recognized based on the intrinsic value method defined by APB Opinion No. 25, “Accounting for Stock Issued to Employees” (“APB No. 25”). Any compensatio...
ommission on February 18, 2014 and incorporated herein by reference. *10.9 Form of Global Non-Qualified Stock Option Agreement for Employees for usage under the Company's Amended and Restated 2006 Stock Incentive Plan, filed as exhibit 10.2 to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended Feb...
Agilent Technologies, Inc. reported restructuring activities across three plans (2001, 2002, and 2003) aimed at returning the company to profitability by reducing the workforce by approximately 16,700 people and exiting over 115 facilities. The 2001 Plan incurred total costs of $533 million through October 31, 2004, wh...
with whom we enter into contracts, against combinations of loss, expense, or liability arising from various triggering events related to the sale and the use of our products and services, the use of their goods and services, the use of facilities and state of our owned facilities, the state of the assets and businesse...
ease from the amounts estimated depending on market conditions and opportunities. 24 CON EDISON ANNUAL REPORT Table of Contents Contractual Obligations The following table summarizes the Companies’ material obligations at December 31, 2012 to make payments pursuant to contracts. Long-term debt, capital lease obligation...
As of October 31, 2004, Agilent Technologies reported that its aggregate projected benefit obligations (PBO) were $718 million for U.S. defined benefit plans and $1,189 million for non-U.S. plans, with plan assets valued at $564 million and $1,109 million respectively. The company expects to contribute $40 million to t...
ent loss — — 5 — 4 7 — — — Special termination benefits — — — — 1 1 — — — Total net plan costs (income) $ 61 $ 90 $ 105 $ 61 $ 75 $ 44 $ 20 $ 22 $ (37 ) Distribution of net plan costs (income): Continuing operations $ 61 $ 90 $ 105 $ 61 $ 75 $ 44 $ 20 $ 22 $ (27 ) Discontinued operations — — — — — — — — (10 ) Total net...
..................................... Internal Revenue Service ITC...................................... Investment Tax Credit IURC................................... Indiana Utility Regulatory Commission KPSC.................................. Kentucky Public Service Commission kV..........................................
This list of exhibits details various corporate agreements for Agilent Technologies, Inc., including executive offer letters, change of control severance agreements, and multiple iterations of stock and deferred compensation plans for employees and non-employee directors. It also includes international lease summaries,...
m 10-Q filed on June 14, 2001. 10.11 Offer letter from the Company to Adrian T. Dillon as incoming Executive Vice President and Chief Financial Officer, dated November 6, 2001. Incorporated by reference from Exhibit 10.15 of the Company’s Form 10-Q filed on March 6, 2002. 10.12 Letter Agreement between Alain Couder and...
re-65 premium costs (subsidy capped at 2011 levels) and a fixed monthly stipend post-65. The subsidy amounts will not increase. In connection with these changes, we reduced our Accumulated Prospective Benefit Obligation by $194 million with the offset going to accumulated other comprehensive income. 89 Table of Content...
Agilent's bio-analytical measurement business employed approximately 4,000 people as of October 31, 2005, and generated revenue of $1.4 billion in fiscal 2005, up from $1.3 billion in 2004 and $1.2 billion in 2003. The business serves life sciences markets (42% of revenue) and chemical analysis markets (58% of revenue)...
s well as marketing to contract manufacturers directly. Our direct sales force consists of field engineers and systems engineers who have in-depth knowledge of the customers' business and technology needs. Our systems engineers provide a combination of consulting, systems integration and application and software engine...
not achieve desired efficiencies and our ability to deliver products to our customers could be disrupted. Although we utilize manufacturing facilities throughout the world, we have been consolidating, and may continue to consolidate, our manufacturing operations to certain of our plants to achieve efficiencies and gros...
Agilent announced a plan to spin off its semiconductor test solutions business, which generated $0.5 billion in revenue in fiscal 2005, into a new automated test company with an expected IPO by mid-year 2006. The business employs approximately 1,600 people and generates more than half of its net revenue from outside th...
acilities in California and Delaware in the U.S., China, Germany and Japan. We utilize just-in-time manufacturing and so typically do not maintain a high level of inventory. Our products typically come with standard warranties, and extended warranties are available for additional cost. Bio-Analytical Measurement Compet...
d such assets in cash (generally in interest-bearing accounts). The anticipated dates on which USCI, USAG, and CPER’s positions in Applicable Interests will be rebalanced on a monthly basis are posted on such Trust Series’ website at www.unitedstatescommodityfunds.com, and are subject to change without notice. USCF emp...
Agilent reported international net revenue of approximately 65% in fiscal 2005 and completed several major transactions, including the $2.6 billion sale of its semiconductor products business to Avago and the $1.7 billion sale of its healthcare solutions business to Philips. The company also noted it is indemnified by ...
ith such indemnified matters, there is no guarantee that such contamination or regulatory non-compliance does not exist, and will not expose us to material liability in the future. We are being indemnified by HP with respect to all environmental liabilities for which HP accrued a reserve, and we are not aware of any ma...
ime, we may purchase forward contracts and options to partially protect against adverse foreign exchange rate movements. Gains or losses on our derivative instruments are largely offset by the gains or losses on the underlying hedged transactions. We do not enter into derivative instruments for trading or speculative p...
The company faces risks from outsourcing manufacturing and IT functions, particularly in developing countries, where failures could impair operations, lead to inventory imbalances, or cause geopolitical and currency-related disruptions. Additionally, the company must navigate the transition to SFAS No. 123R to expense ...
ce on outsourced information technology functions may impair our ability to operate effectively. As part of our efforts to streamline operations and to cut costs, we have been outsourcing and will continue to evaluate additional outsourcing. If our contract manufacturers or other outsourcers fail to perform their oblig...
nd subsurface contamination may require us to incur unreimbursed costs and could harm on-site operations and the future use and value of the properties. We cannot be sure that HP will continue to fulfill its indemnification or remediation obligations. In 25 addition, the determination of the existence and cost of any a...
The company restated fiscal 2004 financial statements to correct an understated U.S. jurisdictional loss, decreasing the 2004 tax provision by $20 million and increasing net income by $20 million. For fiscal 2005, the company reported a $155 million tax provision on continuing operations, an effective tax rate of 52.3 ...
(including Gain) — Lumileds", to our consolidated financial statements. Prior periods' amounts have also been reclassified. Other income (expense), net generally includes interest income, interest expense, rental income, currency gain (loss) on balance sheet remeasurement and other miscellaneous items. Other income (ex...
Registration Statement on Form S-4 filed with the SEC on August 1, 2000 (file number 333-42704)) 4.3 First Supplemental Indenture, dated as of July 28, 2000, by and among Dollar General Corporation, the guarantors named therein, as guarantors, and Wachovia Bank, National Association (formerly known as First Union Natio...
The semiconductor test solutions business reported a total net revenue of $453 million in 2005, a 25% decrease from 2004, while operating margin fell 22 percentage points to (20)% due to competitive pricing, a $22 million inventory charge, and increased R&D spending. The company completed the sale of its semiconductor ...
margin remained flat compared to the same period last year as we invested heavily in research and development and had small headcount increases within selling, general and administrative to accommodate growth. Income from Operations Income from operations increased 6 percent in 2005 compared to 2004 due to increased r...
idate those joint ventures currently not consolidated for financial reporting purposes if the facts and circumstances changed, including but not limited to the following reasons, none of which are currently expected to occur: • For entities not considered to be variable interest entities under FIN 46(R), the nature of ...
Agilent restated its fiscal 2004 financial statements to correct a $20 million understatement of U.S. jurisdictional loss, resulting in a $20 million increase to net income ($0.04 per diluted share). The company reported a 52.3% effective tax rate for fiscal 2005 and recorded a $970 million extraordinary dividend from ...
es 232 242 (3 ) Provision (benefit) for taxes 46 — 10 Net income (loss) from discontinued operations $ 186 $ 242 $ (13 ) 79 The following table presents Agilent's semiconductor products business assets and liabilities: October 31 2005 2004 (in millions) Assets: Accounts receivable $ 219 $ 256 Inventory 178 217 Other cu...
cash and protect their balance sheets. Although Congress and applicable regulatory authorities have enacted legislation and implemented policies and plans designed to free up the credit markets, it is unclear as to whether these actions have been effective to date or will be effective in the future. As the housing indu...
As of October 31, 2005, Agilent reported a standard warranty accrual balance of $46 million and deferred revenue for extended warranties of $89 million. The company also reported a restructuring program (FY05 Plan) resulting in the notification of approximately 1,500 employees for termination and the closure of 116 fac...
ling, general, and administrative ($2 million) in the consolidated statement of operations. 90 13. Guarantees Standard Warranty A summary of the standard warranty accrual activity is shown in the table below, see Note 16, "Other Accrued Liabilities and Other Long-Term liabilities": Years Ended October 31, 2005 2004 (in...
gineering resources and manufacturing scale; continuing to develop high-end 200G/400G products, including RF and packaging designs; exploring high-density, high-bandwidth co-packaged designs through silicon photonics; continuing to develop vertically integrated designs, including with lasers and ICs Coherent optics Dri...
Agilent reported total other accrued liabilities of $179 million and other long-term liabilities of $351 million as of October 31, 2005. During the fiscal year, the company redeemed $1.15 billion of convertible debentures for $692 million in cash, recorded a $7 million loss on the transaction, and repurchased 8.9 milli...
compensation levels 4.0% 4.25% 5.25% Expected long-term return on assets 8.50% 8.75% 8.75% Non-U.S. defined benefit plans: Discount rate 2.25-5.75% 2.0-5.5% 2.25-6.0% Average increase in compensation levels 2.5-4.25% 2.5-4.0% 3.5-4.25% Expected long-term return on assets 4.5-7.5% 5.0-7.5% 5.5-7.75% U.S. post-retiremen...
duction in valuation allowance due to current year decrease in net deferred tax assets, for return to provision true-ups, other adjustments, and OCI impact to deferred taxes. 129 Table of Contents 3. Exhibits. Exhibits are incorporated herein by reference or are filed with this report as indicated below (numbered in ac...
Agilent reported a net income of $25 million for the quarter ended October 31, 2005, including a $42 million gain from discontinued operations and a net loss of $17 million from continuing operations. During the period, the company completed the sale of its semiconductor products business to Avago for $2.579 billion an...
ent. The following table reflects the updated measure of segment assets, capital expenditures and investments in equity-method investees directly managed by each segment. All historical amounts have been reclassified to conform to the current period presentation. Bio-analytical Measurement Electronic Measurement Semico...
ns. If we do not introduce successful new products and services in a timely manner to address increased competition through frequent new product and service introductions, rapid technological changes and changing industry standards, our products and services may become obsolete, and our operating results may suffer. We...
The passage lists various material contracts and agreements for Agilent Technologies, Inc., including stock plans for non-employee directors, deferred compensation plans, and severance agreements for executives such as Adrian T. Dillon, Patrick J. Byrne, and William P. Sullivan. It also details asset purchase agreement...
ock Purchase Plan (Amended and Restated, effective November 1, 2005). Incorporated by reference from Exhibit 10.55 of Company's 10-Q filed September 7, 2005.* 10.24 1999 Non-Employee Director Stock Plan. Incorporated by reference from Exhibit 10.3 of the Company's S-1.* 121 10.25 1999 Non-Employee Director Stock Plan (...
e in short-term investments ( ) ( ) Net derivative instruments settlements ( ) ( ) Private equity contributions ( ) ( ) ( ) Private equity distributions Acquisition of subsidiaries (net of cash acquired of $45, nil, and nil) ( ) Other ( ) ( ) ( ) Net cash flows used for investing activities ( ) ( ) ( ) Cash flows from ...
Agilent's electronic measurement business provides a diverse portfolio of test software, digital design products, and manufacturing test equipment to industries including semiconductors, aerospace, and defense. As of fiscal 2006, no single customer represented more than 10 percent of net revenue, and the company utiliz...
r instruments and test software, digital design products, parametric test products, high frequency electronic design tools, electronics manufacturing test equipment and thin-film transistor array test equipment, nano-positioning systems, atomic-force microscopy and scanning probe microscopy. General purpose instruments...
nd certain direct origination costs are generally deferred and recognized as adjustments to income over the lives of the related loans. As set out in Note 27 on page 200, the Company has elected fair value accounting under SFAS 159 and SFAS 155 for certain loans. Such loans are carried at fair value with changes in fai...
Agilent provides chromatography, mass spectrometry, software, and consumables for the bio-analytical measurement market, reporting roughly 21,000 customers as of fiscal 2006 with no single customer exceeding 10% of net revenue. The company operates global manufacturing facilities in the U.S., China, Germany, and Japan,...
ography Products Agilent is the world's leading provider of gas chromatographs, both laboratory and portable models. A gas chromatograph ("GC") is used to separate any gas, liquid or solid that can be vaporized and then detect the molecules present to determine their identity and quantity. We continue to expand the app...
d increases in accrued salaries and bonuses due to the timing of payments; partially offset by cash outflows primarily related to litigation related payments ($318 million) for the settlement of pricing and sales litigation accrued in prior periods. Investing Activities Net cash used in investing activities was $4.4 bi...
Agilent reported international net revenue of approximately 66% in fiscal 2006 and completed significant transactions including the $949 million sale of its Lumileds stake to Philips and the $2.6 billion sale of its semiconductor products business to Avago. The company also distributed its equity interest in Verigy to ...
that subsurface contamination, it is possible that one or more of the governmental agencies will require us to be named on any of these orders. The naming of Agilent will not affect HP's obligation to indemnify us with regard to these matters. We are liable and are indemnifying HP for any contamination found at all fa...
he following technologies: Liquid Chromatography A liquid chromatograph ("LC") or a high performance liquid chromatograph (“HPLC”) is used to separate molecules of a liquid mixture to determine the quantity and identity of the molecules present. The Agilent LC portfolio is modular in construction and can be configured ...
The electronic measurement business reported a 5% revenue increase in 2006 and a 33% rise in operating income to $479 million, driven by improved gross margins of 56% and restructuring activities. The bio-analytical measurement business achieved 9% revenue growth in 2006 to $1,554 million, with significant demand in ch...
work monitoring market. General purpose test revenues grew 11 percent over 2005, with strength in semiconductor design and verification, aerospace/defense and consumer electronic manufacturing 45 applications. In 2005 segment revenues increased 1 percent compared to 2004 due to the strength of our signal analyzers and ...
capacity. Production from the field has been reduced since January 2020, due to the rupture of a third-party pipeline which carries gas production from KBB to market. The pipeline operator has initiated repairs with no production expected to flow through the full length of the pipeline during 2021. Block G Malikai We h...
In 2006, Agilent Technologies reported net cash provided by investing activities of $1,838 million and used $2,548 million in financing activities, which included a $4.466 billion stock repurchase program and a $1.5 billion long-term debt obligation from a Master Repurchase Agreement. The company also completed the $2....
n under the American Jobs Creation Act of 2004, and with the 2005 federal alternate minimum tax. We also made higher disbursements for restructuring activities of $166 million during 2006, primarily in the form of severance payments, compared to $110 million during 2005. The restructuring payments were more than offset...
nts; molecular spectroscopy instruments; software and data systems; vacuum pumps and measurement technologies; services and support for our products. 42 Table of Contents Orders and Net Revenue Years Ended October 31, 2013 over 2012 Change 2012 over 2011 Change 2013 2012 2011 (in millions) Orders $ 1,642 $ 1,604 $ 1,58...
Agilent distributed Verigy's net assets, which had a book value of $598 million in assets and $295 million in liabilities as of October 31, 2006. The company also disclosed share-based compensation plans, including an ESPP with 23,341,919 shares available for issuance and a Stock Plan with 36,639,572 shares registered ...
term liabilities 12 Long term liabilities of discontinued operations 12 Total liabilities of discontinued operations $ 116 75 The following table presents Agilent's book value of net assets eliminated due to the distribution as of October 31, 2006: October 31, 2006 (In millions) Assets: Cash $ 300 Accounts receivable 1...
he various impacts of the Tax Act below. SEC Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (which we refer to as SAB 118) describes three scenarios associated with a company’s status of accounting for income tax reform. Under the SAB 118 guidance, we made reasonable ...
For the fiscal year ended October 31, 2006, Agilent reported a total income tax provision from continuing operations of $91 million, with an effective tax rate of 6.0% primarily impacted by a $30.0 million valuation allowance. The company reported a $901 million gain from the sale of Lumileds (net of taxes) and maintai...
taxes — Gain from sale of Lumileds, net of taxes $ 901 The tax impact of the sale of our Lumileds joint venture primarily reflects the utilization of valuation allowances within the U.S. 85 8. Provision (Benefit) For Income Taxes From Continuing Operations The provision (benefit) for income taxes from continuing opera...
re recognized in earnings as swap payments are made. 6. Secured Notes Payable Secured notes payable consist of the following (in thousands): December 31, ------------------- 2001 2000 --------- --------- 8.75% note, due January 2006, with an effective interest rate of 7.25% (includes unamortized premium of $494 and $61...
As of October 31, 2006, Agilent reported a restructuring accrual of $71 million and disclosed future operating lease commitments of $79 million for 2007, with total restructuring and asset impairment charges of $186 million for the fiscal year ended October 31, 2006. The company also reported that various indemnificati...
Verigy to effect the IPO, arising out of the distribution of Agilent's remaining holding in Verigy ordinary shares to Agilent's stockholders, or incurred to effect the separation of the semiconductor test solutions business from Agilent to the extent incurred prior to the separation on June 1, 2006. In our opinion, the...
INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) valuation principles. We adopted the guidance in the quarter ended October 31, 2009, and there was no material impact on our consolidated financial statements. In September 2009, the FASB amended the guidance concerning fair value measurements of investments...
For the fiscal year ended October 31, 2006, Agilent reported total net revenue of $4,973 million, with the Electronic Measurement segment contributing $3,419 million and the Bio-analytical Measurement segment contributing $1,554 million. The company reported a net income of $149 million for the fourth quarter of 2006, ...
onductor test systems business, but not classified within discontinued operations, were not reallocated to our other segments. These charges are presented below as a component of the reconciliation between the segments' income from operations and Agilent's income from continuing operations and are classified as unalloc...
s to Consolidated Financial Statements, Continued N OTE 7. D ERIVATIVES A ND H EDGE A CCOUNTING A CTIVITIES The Companies are exposed to the impact of market fluctuations in the price of electricity, natural gas and other energy-related products they market and purchase, as well as interest rate and foreign currency ex...
The passage lists various Agilent Technologies, Inc. corporate agreements, including international award agreements for the 1999 Stock Plan, employee and non-employee director stock plans, deferred compensation plans, and specific compensation and severance agreements for executives such as Adrian T. Dillon, William P....
ward Agreement (Belgium) for grants under the Agilent Technologies, Inc. 1999 Stock Plan. Incorporated by reference from Exhibit 10.29 of the Company's 10-K filed December 21, 2004.* 10.12 Form of Award Agreement (Brazil) for grants under the Agilent Technologies, Inc. 1999 Stock Plan. Incorporated by reference from Ex...
operty, where permission to operate can be revoked. In addition, Virginia Power owns 486 substations. 45 The following tables list Virginia Power’s generating units and capability as of December 31, 2024. VIRGINIA POWER UTILITY GENERATION Plant Location Net Summer Capability (MW) Percentage Net Summer Capability Gas Gr...
Agilent sells a diverse range of electronic measurement products, including general purpose instruments, modular test software, digital design tools, and manufacturing test equipment to customers in the semiconductor, aerospace, and communications industries. As of the end of fiscal 2007, no single customer represented...
experience for broadband, data, wireless and converged networks and services. General Purpose Test Products We sell the following types of products into the general purpose test market: general purpose instruments, modular instruments and test software, digital design products, parametric test products, high frequency ...
the time of the sale plus adjustments for the final purchased net assets. For incremental fees, we provided support services to Philips after August 1, 2001 and a portion of these fees offset costs that include an element of fixed costs which are recognized in selling, general and administrative expenses in 2001 and 20...
Agilent expanded its life sciences and analytical portfolio through the 2005 acquisitions of Scientific Software, Inc. and Silicon Genetics, Inc., the 2006 purchase of GE's chemiluminescence line, and the 2007 acquisition of Stratagene Corporation. The company offers a diverse range of products including microfluidics,...
he areas of comparative human genomics (CGH) and micro RNA detection. Microfluidics Products The Agilent 2100 bioanalyzer is the first commercial microfluidics product for the analysis of a wide range of biological molecules, including DNA, RNA, proteins and cells. The bioanalyzer chips 10 allow sample quality assessme...
production is expected to continue until 2017. The project is estimated to cost $5.6 billion. Proved reserves have been recognized for this project. A project to develop the Greater Longui Area of Block 0 is expected to enter FEED in first-half 2014. FEED activities progressed during 2013 on the south extension of the ...
Agilent reports that international net revenue was approximately 66% in fiscal 2007, with 12% derived from Japan, while long-lived assets outside the U.S. accounted for 55% of total long-lived assets in fiscal 2007. The company manages supply chain risks through multiple sourcing and inventory buffers, and it maintains...
terial. In addition, our intellectual property rights may be challenged, invalidated or circumvented or may otherwise not provide significant competitive advantage. Materials Our manufacturing operations employ a wide variety of semiconductors, electromechanical components and assemblies and raw materials such as plast...
INC. NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued) valuation principles. We adopted the guidance in the quarter ended October 31, 2009, and there was no material impact on our consolidated financial statements. In September 2009, the FASB amended the guidance concerning fair value measurements of investments...
The company faces potential risks from divestitures, including difficulties in transferring liabilities and intellectual property, and from environmental contamination liabilities, specifically regarding subsurface contamination where HP has agreed to indemnify the company for certain past operations. Additionally, the...
of key customers; • the compatibility of our sales programs and facilities within those of the acquired company; and • the compatibility of our existing infrastructure with that of an acquired company. A successful divestiture depends on various factors, including our ability to: • effectively transfer liabilities, con...
y may elect to have a portion, or all, of their compensation deferred. The amounts allocated to each participant's compensation account may be converted into common stock units. Upon termination or death of a participant, the Company is required to distribute, under various methods, cash or the number of shares of comm...
In 2007, the bio-analytical measurement business reported total net revenue of $2,005 million (up 20% from 2006) and orders of $2,026 million (up 17% from 2006). Income from operations increased by $24 million in 2007, with growth driven by revenue increases of $113 million and gross margin improvements, partially offs...
ear-over-year in 2007 as margin improvements due to lower infrastructure costs, lower material costs and a functional change in corporate overhead classification were partially offset by changes in product mix. Gross margin for products and services increased 3 percentage points from 2005 to 2006, a period of significa...
ely be made with incomplete information; pose the risk that such actions may prove to be premature, incorrect or insufficient; and could have a material, adverse impact on our business and results of operations. Our operating results and financial condition could be harmed if the markets into which we sell our products...
Agilent reported share-based compensation expenses of $3 million for the semiconductor products business and $11 million for the semiconductor test solutions business in fiscal 2006, following the Verigy spin-off and modifications to the FY2005 LTPP program. As of October 31, 2007, the company held 45,216 outstanding o...
ation of the FY2005 LTPP program. In September 2007, our Board of Directors approved a modification that removed the performance metric from the payout computation for the FY2005 program only. The modification changed the award payout calculation to be based exclusively on the market metric. The number of shares to be ...
s solution comprises a line of oligonucleotide probes for Fluorescent In Situ Hybridization ('FISH') called SureFISH. Over 400 probes are available in our catalog, covering most relevant regions in the genome. Cytogenetic labs can use SureFISH probes to detect specific translocations or copy number changes in samples. ...
The company reported a gain of $901 million from the sale of Lumileds in 2006, net of taxes, and reported an effective tax rate of 4.8% for the fiscal year ended October 31, 2007. Significant tax assets and liabilities were reported as of October 31, 2007, including $301 million in federal net operating loss carryforwa...
cipal debt and accrued interest due to us as of the date of sale under the Credit Agreement, dated as of November 30, 2001. The following table shows the components of the gain from sale of Lumileds, net of income tax: Year Ended October 31, 2006 (in millions) Proceeds $ 949 Net book value of investments (48 ) Gain on ...
Exercisable............................................ 4,258 5,706 3,943 Weighted average exercise price: Options granted..................................... $ 81.69 $ 53.33 $ 74.92 Options exercised................................... 32.12 20.29 18.70 Options terminated.................................. 59.30 58.31 ...
Agilent reported pension liability impacts including a $170 million additional minimum liability in Europe and a $112 million impact on accumulated comprehensive gain, while also projecting $42 million in total contributions to U.S. and non-U.S. defined benefit plans for fiscal year 2008. The company also reported a $1...
ans in Europe as the accumulated benefit obligation exceeded the fair value of pension plan assets for those plans as of the measurement date. The impact of the additional minimum liability on accumulated comprehensive loss was $170 million, which was partially offset by $20 million applied to deferred tax assets, net ...
tization methodology for DAC related to Allstate Financial policies and contracts includes significant assumptions and estimates. DAC related to traditional life insurance is amortized over the premium paying period of the related policies in proportion to the estimated revenues on such business. Significant assumption...
Agilent Technologies reported a $600 million senior note issuance in October 2007 with a 6.50% fixed interest rate, offset by a $600 million interest rate swap to convert to a variable LIBOR-based rate. The company also maintains a $1.5 billion long-term debt obligation from a 2006 Master Repurchase Agreement, a $300 m...
included in continuing operations 12 172 108 Restructuring and asset impairment charges included in discontinued operations, semiconductor products business — — 10 Restructuring and asset impairment charges included in discontinued operations, semiconductor test solutions business — 14 5 Total restructuring and asset i...
ccumulates a retirement benefit consisting of pay credits that are based upon a percentage (which varies with age and years of service) of current eligible earnings and current interest credits. Certain legacy Cinergy employees are covered under plans that use a final average earnings formula. Under a final average ear...
The report includes Schedule II for tax valuation allowances, showing a balance of $332 thousand for 2007, and lists numerous exhibits including separation agreements with Hewlett-Packard and Agilent Technologies, Inc., as well as various award agreements under the Agilent Technologies, Inc. 1999 Stock Plan.
s report. Information regarding securities authorized for issuance under equity compensation plans appears in Item 5 of this report. Item 13. Certain Relationships and Related Transactions, and Director Independence Information about certain relationships and related transactions appears under "Certain Relationships an...
emulation and acceleration, including the verification computing platform Palladium ® XP, Palladium and Xtreme ® platforms, system-level design capabilities, VIP, estimation of SoC cost and performance, consulting services, and methodologies that provide customers with automation for hardware-software verification and ...
Agilent Technologies reported that its electronic measurement business generated $3.5 billion in revenue in fiscal 2008, with the communications test market accounting for 42% of that revenue and the general purpose test market accounting for 58%. The company also disclosed the 2005-2006 divestiture of its semiconducto...
ess segments comprised of the electronic measurement business, the bio-analytical measurement business and the semiconductor and board test business. The new semiconductor and board test segment will combine laser interferometer, parametric test and printed circuit board manufacturing test equipment. At the same time, ...
financial results. If we are required to account for options under our employee stock plans as a compensation expense, our net income and net income per share would be significantly reduced. There has been an increasing public debate about the proper accounting treatment for employee stock options. Currently we would r...
The bio-analytical measurement business employed approximately 5,500 people as of October 31, 2008, and generated revenue of $2.3 billion in fiscal 2008, $2.0 billion in fiscal 2007, and $1.7 billion in fiscal 2006. In 2008, revenue from this business was comprised of approximately 45 percent from life sciences markets...
marily on final assembly and test of our products. To maximize our productivity and our ability to respond to market conditions, we use contract manufacturers for the production of printed circuit boards, sheet metal fabrication, metal die-casting, plastic molding and standard electronic components. We also manufacture...
curities 10,615 1,132 - (1,849) 446 (1,421) 8,923 298 Equity securities available for sale: Common stock 1 - - (1) 2 (1) 1 - Preferred stock - - - - - - - - Mutual funds - - - - 1 (1) - - Total equity securities available for sale 1 - - (1) 3 (2) 1 - Mortgage and other loans receivable - - - 6 - - 6 - Other invested as...